Discontinuation of biological agents without functional and structural damage progression after attaining sustained remission in patients with rheumatoid arthritis
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000022596
- Lead Sponsor
- Department of Hematology and Rheumatology, Kinki University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patients who refused to join this study.2) The patients who prescribed up-dose in DMARDS, steroids, and NSAIDs and done the joint injection 3) severe infection 4) demyelinating disease (multiple sclerosis), 5) congestive heart failure, 6) Patient who is lactating, pregnant, possibly pregnant or do not agree with the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method